21Candida albicans is known for its ability to form biofilmscommunities of 22 microorganisms embedded in an extracellular matrix developing on different 23 surfaces. Biofilms are highly tolerant to antifungal therapy. This phenomenon has 24 been partially explained by the appearance of so-called persister cells, phenotypic 25 variants of wild-type cells, capable of surviving very high concentrations of 26 antimicrobial agents. Persister cells in C. albicans were found exceptionally in 27 biofilms while none were detected in planktonic cultures of this fungus. Yet, this topic 28 remains controversial as others could not observe persister cells in biofilms formed 29 by the C. albicans SC5314 laboratory strain. Due to ambiguous data in the literature, 30this work aimed to reevaluate the presence of persister cells in C. albicans biofilms. 31We demonstrated that isolation of C. albicans "persister cells" as described 32previously was likely to be the result of survival of biofilm cells that were not reached 33by the antifungal. We tested biofilms of SC5314 and its derivatives, as well as 95 34 clinical isolates, using an improved protocol, demonstrating that persister cells are 35 not a characteristic trait of C. albicans biofilms. Although some clinical isolates are 36 able to yield survivors upon the antifungal treatment of biofilms, this phenomenon is 37 rather stochastic and inconsistent. 38 39 40 48 develop on different types of surfaces, either living or inert, and are characterized by 49 their high tolerance to antifungals. The latter can result from the properties of the 50 extracellular matrix that can serve as a trap for drug molecules (5-7). An additional 51 source of antifungal tolerance has been proposed to result from the occurrence in 52 biofilms of so-called persister cells, a subpopulation of phenotypic variants of wild-53 type cells, capable of surviving concentrations of antimicrobial agents well above the 54 Minimal Inhibitory Concentration (MIC) (8). Persister cells are genetically identical to 55 other biofilm cells. Upon removal of the antimicrobial agent they give rise to a new 56 population comprised of the majority of susceptible cells and a new small 57 subpopulation of persisters. Thus, persistence is a non-inherited trait (9-11). 58 In the clinical setting, persisters are usually associated with relapse of infections and 59 with the development of chronic infections. For bacterial persisters, several 60 mechanisms and pathways involved in their development have been described (12). 61 In 2006, LaFleur et al. have presented the first report of persister cells in biofilms of 62C. albicans, which could contribute to biofilm tolerance to antifungals (8). In their 63 paper the authors have reported that C. albicans exhibit a biphasic killing curve, 64 when exposed to the antifungals such as amphothericin B (AMB), chlorhexidine or 65 4 the combination of both. This phenomenon is explained by the presence of a 66 multidrug-tolerant subpopulation of persister cells within a biofilm. Notably, the ...